Article info

Download PDFPDF
Oral water-soluble contrast (Gastrografin) for malignant bowel obstruction: open label pilot study

Authors

  • Wan Fadzrul Izuan Bin Wan Bahrum Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, AustraliaDepartment of Palliative Care, St Vincent's Private Hospital, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Janet Hardy Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, AustraliaMater Research - University of Queensland, South Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Karyn Foster Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, AustraliaMater Research - University of Queensland, South Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Phillip Good Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, AustraliaDepartment of Palliative Care, St Vincent's Private Hospital, Brisbane, Queensland, AustraliaMater Research - University of Queensland, South Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Karyn Foster, Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, Australia; karyn.foster{at}mater.org.au
View Full Text

Citation

Wan Bahrum WFIB, Hardy J, Foster K, et al
Oral water-soluble contrast (Gastrografin) for malignant bowel obstruction: open label pilot study

Publication history

  • Received October 26, 2021
  • Accepted December 27, 2021
  • First published January 19, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.